Showing 151-160 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A prodrug system for targeted activation of small molecules in beta cells | The Brigham and Women’s Hospital, Inc. | Amit Choudhary | Cures | 01-February-2024 to 31-January-2027 | $2,250,000.00 |
| Expanding Access to T1D Care through the PEN-Plus Strategy | The Brigham and Women’s Hospital, Inc. | Gene Bukhman | Mission | 01-August-2024 to 31-July-2027 | $5,999,961.29 |
| Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-May-2023 to 30-April-2026 | $749,763.00 |
| Immune-cell targeted TLR7 antagonist to halt the attack on beta−cells in the context of Type 1 Diabetes | Tezcat Bio | Craig Ramirez | Cures | 15-January-2026 to 31-December-2026 | $100,000.00 |
| Research and Data Research | T1D Exchange, Inc. | Jaime Lucove | Transportfolio | 01-December-2022 to 30-November-2025 | $620,435.07 |
| Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes | T1D Exchange, Inc. | Nicole Rioles | Improving Lives | 01-May-2024 to 30-April-2027 | $1,995,534.06 |
| Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology | Syntax Bio, Inc | Ryan Clarke | Cures | 15-November-2025 to 14-November-2027 | $856,250.00 |
| Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D | Stanford University | Ananta Addala | Improving Lives | 01-February-2025 to 31-January-2029 | $943,983.20 |
| Development of Uni-molecular Glucose-responsive Insulin | Stanford University | Danny Hung-Chieh Chou | Improving Lives | 01-April-2022 to 31-March-2026 | $749,998.34 |
| Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-December-2026 | $795,000.00 |